Your browser doesn't support javascript.
loading
Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis.
Xia, Lu; Hantrakun, Viriya; Teparrukkul, Prapit; Wongsuvan, Gumphol; Kaewarpai, Taniya; Dulsuk, Adul; Day, Nicholas P J; Lemaitre, Rozenn N; Chantratita, Narisara; Limmathurotsakul, Direk; Shojaie, Ali; Gharib, Sina A; West, T Eoin.
Afiliação
  • Xia L; Department of Biostatistics.
  • Hantrakun V; Mahidol Oxford Tropical Medicine Research Unit.
  • Teparrukkul P; Department of Internal Medicine, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand; and.
  • Wongsuvan G; Mahidol Oxford Tropical Medicine Research Unit.
  • Kaewarpai T; Department of Microbiology and Immunology, and.
  • Dulsuk A; Department of Microbiology and Immunology, and.
  • Day NPJ; Mahidol Oxford Tropical Medicine Research Unit.
  • Lemaitre RN; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Chantratita N; Cardiovascular Health Research Unit and.
  • Limmathurotsakul D; Mahidol Oxford Tropical Medicine Research Unit.
  • Shojaie A; Department of Microbiology and Immunology, and.
  • Gharib SA; Mahidol Oxford Tropical Medicine Research Unit.
  • West TE; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Am J Respir Crit Care Med ; 209(3): 288-298, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-37812796
ABSTRACT
Rationale The global burden of sepsis is greatest in low-resource settings. Melioidosis, infection with the gram-negative bacterium Burkholderia pseudomallei, is a frequent cause of fatal sepsis in endemic tropical regions such as Southeast Asia.

Objectives:

To investigate whether plasma metabolomics would identify biological pathways specific to melioidosis and yield clinically meaningful biomarkers.

Methods:

Using a comprehensive approach, differential enrichment of plasma metabolites and pathways was systematically evaluated in individuals selected from a prospective cohort of patients hospitalized in rural Thailand with infection. Statistical and bioinformatics methods were used to distinguish metabolomic features and processes specific to patients with melioidosis and between fatal and nonfatal cases. Measurements and Main

Results:

Metabolomic profiling and pathway enrichment analysis of plasma samples from patients with melioidosis (n = 175) and nonmelioidosis infections (n = 75) revealed a distinct immuno-metabolic state among patients with melioidosis, as suggested by excessive tryptophan catabolism in the kynurenine pathway and significantly increased levels of sphingomyelins and ceramide species. We derived a 12-metabolite classifier to distinguish melioidosis from other infections, yielding an area under the receiver operating characteristic curve of 0.87 in a second validation set of patients. Melioidosis nonsurvivors (n = 94) had a significantly disturbed metabolome compared with survivors (n = 81), with increased leucine, isoleucine, and valine metabolism, and elevated circulating free fatty acids and acylcarnitines. A limited eight-metabolite panel showed promise as an early prognosticator of mortality in melioidosis.

Conclusions:

Melioidosis induces a distinct metabolomic state that can be examined to distinguish underlying pathophysiological mechanisms associated with death. A 12-metabolite signature accurately differentiates melioidosis from other infections and may have diagnostic applications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Burkholderia pseudomallei / Sepse / Melioidose Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Burkholderia pseudomallei / Sepse / Melioidose Idioma: En Ano de publicação: 2024 Tipo de documento: Article